Direktorat Registrasi ObatValid

RANITIDINE HCL

BPOM Number: GKL2317632243A1
Approved: 21 November 2024
Expiry: 27 December 2028
Form: INJEKSI; 27,9 MG

About This Registration

RANITIDINE HCL is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2317632243A1. Its current registration status is Valid, with the licence valid until 27 December 2028. The product is registered to INTERBAT - INDONESIA. BPOM first approved this registration in December 2023. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 10 AMPUL @ 2 ML
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

INTERBAT - INDONESIA
KAB. SIDOARJO
NPWP: 010019172073000
owner
View profile →

Manufacturing Sites

INTERBAT - INDONESIA
KAB. SIDOARJO
primary
View profile →

Ingredients (1)

RANITIDINE HYDROCHLORIDE

Market Intelligence

Owner Portfolio: INTERBAT - INDONESIA holds 339 BPOM registrations
Manufacturer Scale: INTERBAT - INDONESIA produces 339 registered products
Registration Age: Registered for 2 years, 8 months

FDA Cross-Reference

via openFDA

Generic Name: RANITIDINE
Product Type: HUMAN OTC DRUG
Route of Administration: ORAL
Purpose: Purpose Acid reducer

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?